Discover Arrowhead Pharmaceuticals, Inc.'s latest 8-K filing on February 10, 2025, detailing critical updates for investors and stakeholders. Ticker: ARWR, NASDAQ.
Explore NeuroSense Therapeutics Ltd.'s latest Form 6-K revealing a binding term sheet for PrimeC in ALS treatment, signaling potential advancements and market impact.
Explore CTD Holdings' Q1 2015 financial performance, revealing a 69% revenue drop and operational losses. Key insights on cash position and strategic outlook included.
Explore Cyclo Therapeutics, Inc.'s Q1 2021 financial report summary, highlighting key losses, cash reserves, and recommendations for investors amid ongoing drug development challenges.